Regeneron Pharmaceuticals, Inc.

Equities

REGN

US75886F1075

Market Closed - Nasdaq Other stock markets 04:00:00 2026-05-13 pm EDT			5-day change	1st Jan Change
719.88 ^USD	-0.49%		-0.16%	-6.74%

May. 12	Regeneron Pharmaceuticals, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 10:00 AM
May. 05	Regeneron Pharmaceuticals, Inc. and Sanofi Demonstrate Dupixent Shows Improved Esophageal Function in Eosinophilic Esophagitis Phase 4 Trial	CI

Transcript : Regeneron Pharmaceuticals, Inc. Presents at Bernstein Insights

Published on 09/24/2025 at 12:50 pm EDT - Modified on 09/24/2025 at 01:35 pm EDT

S&P Capital IQ

Presenter Speech
William Pickering (Analysts)

Good morning, everyone. My name is Will Pickering. I cover U.S. biotech at Bernstein. Very pleased today to have Regeneron Pharmaceuticals with us. I'm

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Regeneron Pharmaceuticals, Inc.

May. 12	Regeneron Pharmaceuticals, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 10:00 AM
May. 05	Regeneron Pharmaceuticals, Inc. and Sanofi Demonstrate Dupixent Shows Improved Esophageal Function in Eosinophilic Esophagitis Phase 4 Trial	CI
May. 04	Global pharma companies that have publicly announced Trump drug pricing agreements	RE
May. 01	Rothschild & Co Redburn Adjusts Regeneron Pharmaceuticals PT to $1,000 From $950	MT
May. 01	Guggenheim Adjusts Regeneron Pharmaceuticals Price Target to $995 From $975	MT
Apr. 30	Regeneron's Eylea Franchise on 'Solid Footing' Despite HD Sales Miss in Q1, Oppenheimer Says	MT
Apr. 30	Morgan Stanley Adjusts Regeneron Pharmaceuticals PT to $788 From $796	MT
Apr. 30	Raymond James Adjusts Regeneron Pharmaceuticals Price Target to $902 From $910	MT
Apr. 30	Leerink Partners Adjusts Regeneron Pharmaceuticals Price Target to $792 From $873	MT
Apr. 30	Barclays Adjusts Regeneron Pharmaceuticals Price Target to $917 From $923	MT
Apr. 30	Goldman Sachs Adjusts Regeneron Pharmaceuticals Price Target to $968 From $967	MT
Apr. 30	Cantor Fitzgerald Adjusts Regeneron Pharmaceuticals PT to $800 From $779	MT
Apr. 30	Wells Fargo Adjusts Regeneron Pharmaceuticals PT to $800 From $825	MT
Apr. 30	Bernstein Adjusts Regeneron Pharmaceuticals PT to $916 From $913	MT
Apr. 30	RBC Trims Price Target on Regeneron Pharmaceuticals to $762 From $779, Keeps Sector Perform Rating	MT